Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rhuta Meharunkar"'
Autor:
Abhay Chowdhary, Rhuta Meharunkar, Devanshi J. Gohil, Rajas Warke, Sweta T. Kothari, Pramod Shinde, Ranjana A Deshmukh
Publikováno v:
Current Microbiology. 74:899-907
Pandemic influenza A (H1N1) 2009 virus was first detected in India in May 2009 which subsequently became endemic in many parts of the country. Influenza A viruses have the ability to evade the immune response through its ability of antigenic variatio
Autor:
Anand S. Chintakrindi, Sweta T. Kothari, Pramod Shinde, Abhay Chowdhary, Meena Kanyalkar, Devanshi J. Gohil, Rhuta Meharunkar, Ranjana A Deshmukh, Rajas Warke
Publikováno v:
Infection, Genetics and Evolution. 29:75-81
Objective From its first instance in 1977, resistance to amantadine, a matrix (M2) inhibitor has been increasing among influenza A/H3N2, thus propelling the use of oseltamivir, a neuraminidase (NA) inhibitor as a next line drug. Information on drug s
Autor:
Ranjana A Deshmukh, Rhuta Meharunkar, Abhay Chowdhary, Rajas Warke, Pramod Shinde, Devanshi J. Gohil, Sweta T. Kothari, Meena Kanyalkar, Chintakrindi
Publikováno v:
Journal of Antivirals & Antiretrovirals. 7
Objectives: Oseltamivir is an important antiviral agent approved for treatment of infections caused by Influenza virus. The emergence of an Oseltamivir resistant seasonal Influenza A (H1N1) virus in 2007 in Norway and pandemic Influenza A (H1N1) viru